Unopposed oestrogens (oral)
Unopposed oestrogens (transdermal)
Unopposed oestrogens (gel)
Prescribing Notes
- HRT preparations should be brand prescribed to aid product identification
- It is recommended that the lowest dose of HRT based on relieving menopausal symptoms should be prescribed
- Women with an early menopause (<45 years), especially if surgically induced, require the higher dose of oestrogen to control their vasomotor symptoms and for bone protection
- Mirena® is licensed for 4 years for endometrial protection during oestrogen replacement therapy (i.e. Mirena® provides the progestogen component of HRT). In practice, it is used for up to 5 years, providing the woman is not experiencing bleeding
Preparations for vaginal atrophy
See section 7.2.1